Alcobra (ADHD) To Release First Quarter 2014 Results And Host Investor Conference Call On Thursday, May 15, 2014
5/8/2014 10:02:15 AM
TEL AVIV, Israel, May 7, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging biopharmaceutical company focused on the development of new medications to help patients with cognitive disorders, including Attention Deficit Hyperactivity Disorder (ADHD) and Fragile X Syndrome, today announced that it will report its financial results for the first quarter of 2014 and will host a corporate update conference call on Thursday, May 15, 2014.
Help employers find you! Check out all the jobs and post your resume.
comments powered by